RBC Capital Reiterates Outperform on Sophia Genetics, Maintains $8 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara has reiterated an Outperform rating on Sophia Genetics (NASDAQ:SOPH) and maintained an $8 price target.
March 06, 2024 | 3:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital maintains an Outperform rating and an $8 price target on Sophia Genetics.
The reiteration of an Outperform rating and maintenance of an $8 price target by a reputable analyst like Conor McNamara from RBC Capital could instill confidence among investors and potentially lead to a positive short-term impact on SOPH's stock price. Analyst ratings and price targets are significant indicators for investors, often influencing stock performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100